InhaleRx Limited announced a private placement of convertible loan facility for the gross proceeds of AUD 500,000 on March 28, 2024. The loan will have a coupon rate of 10%. The loan will have a term of 2 years and will be convertible into common shares at a price of AUD 0.05 per share.

The transaction will include participation from new investor, Peak Asset Management, LLC.